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Abstract 25 
Background: Preclinical osteoarthritis models where damage occurs spontaneously 26 
may better reflect the initiation and development of human osteoarthritis. The aim 27 
was to assess the commercial pig as a model of spontaneous osteoarthritis 28 
development by examining pain-associated behaviour, joint cartilage integrity, as 29 
well as the use of porcine cartilage explants and isolated chondrocytes and 30 
osteoblasts for ex vivo and in vitro studies.  31 
Methods: Female pigs (Large white x Landrace x Duroc) were examined at different 32 
ages from 6 weeks to 3-4 years old.  Lameness was assessed as a marker of pain-33 
associated behaviour. Femorotibial joint cartilage integrity was determined by 34 
chondropathy scoring and histological staining of proteoglycan. IL-6 production and 35 
proteoglycan degradation was assessed in cartilage explants and primary porcine 36 
chondrocytes by ELISA and DMMB assay. Primary porcine osteoblasts from 37 
damaged and non-damaged joints, as determined by chondropathy scoring, were 38 
assessed for mineralisation, proliferative and mitochondrial function as a marker of 39 
metabolic capacity.   40 
Results: Pigs aged 80 weeks and older exhibited lameness.  Osteoarthritic lesions 41 
in femoral condyle and tibial plateau cartilage were apparent from 40 weeks and 42 
increased in severity with age up to 3-4 years old. Cartilage from damaged joints 43 
exhibited proteoglycan loss, which positively correlated with chondropathy score. 44 
Stimulation of porcine cartilage explants and primary chondrocytes with either IL-1β 45 
or visfatin induced IL-6 production and proteoglycan degradation. Primary porcine 46 
osteoblasts from damaged joints exhibited reduced proliferative, mineralisation, and 47 
metabolic capacity.  48 
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Conclusion: In conclusion, the commercial pig represents an alternative model of 49 
spontaneous osteoarthritis and an excellent source of tissue for in vitro and ex vivo 50 
studies. 51 
Keywords: osteoarthritis, osteoblast, chondropathy, pig, chondrocyte 52 
 53 
Background 54 
Osteoarthritis (OA) is an age-related joint disorder and the most common 55 
degenerative joint disorder in the World [1].  Characterised by degenerative loss of 56 
the articular cartilage, joint space narrowing, synovial inflammation and bone 57 
remodelling [2], it is a leading cause of disability and pain.  Unfortunately, at present 58 
there are no available disease modifying OA drugs (DMOADs) [2, 3]. As an ageing 59 
population OA is a major health concern since it limits independence, reduces an 60 
individual’s quality of life and puts additional pressure on healthcare systems and 61 
elderly support services [4, 5] . 62 
Critically, the development of DMOADs has been hampered by a lack of 63 
understanding of the joint pathology in early OA.  Unfortunately, investigating early 64 
OA joint pathology in humans is inherently difficult.  Synovial tissue and synovial joint 65 
fluid can be collected from early OA patients by arthroscopy procedures.  However, 66 
OA diseased cartilage and bone tissue of sufficient quantity can generally only be 67 
obtained from end-stage diseased patients who are undergoing elective joint 68 
replacement surgery.  Cartilage tissue from end-stage OA patients is often highly 69 
degraded and is therefore of questionable relevance to our understanding of the 70 
central pathways that underpin the initiation and development of early degenerative 71 
changes in the human OA joint. Furthermore, many of the in vivo preclinical models 72 
that are utilised are artificial models [6] where OA is experimentally induced either 73 
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chemically or surgically.  Surgical induction of OA is achieved by destabilising the  74 
joint through the surgical damage of joint ligaments, for example anterior cruciate 75 
ligament tear in the dog [7]  or more recently in mice through the destabilisation of 76 
the medial meniscus (DMM model) [8, 9].  Although these models are effective in 77 
inducing joint damage, they more likely reflect changes seen in traumatically induced 78 
OA, where an injury has triggered further damage, rather than age-related OA [6, 8, 79 
10].   80 
For studying age-related human OA onset, animal models that spontaneously 81 
develop OA are likely to be more translatable.  Such translation is critical to the 82 
development of new OA drugs.  Indeed, the greatest reason for late-stage failure of 83 
candidate drugs can be traced back to failure of preclinical target validation studies 84 
to translate in the clinic [11].  In this regard, the Dunkin Hartley guinea pig is a 85 
notable example [12]. These animals develop OA without surgical, chemical or 86 
environmental manipulation [12, 13].  However, the quantity of joint tissue for ex vivo 87 
and in vitro studies can be limiting. Spontaneous development of OA has also been 88 
studied in large animals including horse [14] and dog [15].  However, the major 89 
drawback with these models is the long timescale for OA development, which can 90 
make studies prohibitively expensive and ultimately unfeasible. Furthermore, public 91 
resistance to the use of companion animal species in biomedical research also 92 
presents additional challenges. 93 
In contrast to the above models, commercial pigs have been reported to develop 94 
spontaneous joint pathologies at a young age, resulting in pigs often being 95 
slaughtered due to lameness [16].  However, no study had previously examined 96 
whether the commercial pig develops signs of OA joint damage. The aim of this 97 
study was two-fold. Firstly, to assess pain-associated behaviour and femorotibial 98 
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joint pathology for signs of spontaneous development of OA in commercial pigs from 99 
juvenile to older adult.  Secondly, to assess the potential utility of porcine cartilage 100 
explants and isolated porcine chondrocytes and osteoblasts for in vitro and ex-vivo 101 
preclinical studies.  102 
 103 
Methods 104 
Animals 105 
Female pigs (Large white x Landrace x Duroc) aged 6-10 wks (n=8, weight 37.4 ± 106 
1.4 kg), 17 wks (n=6, weight 84.0 ± 2.2kg), 40 wks (n=6, weight 141.2 ± 4.2kg), 63 107 
wks (n=8, weight 245.1 ± 9.0kg), and 3-4 years (n=7, weight 230.6 ± 9.0kg) 108 
purchased from JSR Genetics Ltd (Driffield, UK) were used in this pilot study to 109 
examine the incidence of the development of osteoarthritis. For comparison 110 
purposes animals were characterised by age in to three groups: juvenile (age range 111 
6-17 wk), adult (40-80 wk), and older adult (3-4 years). The juvenile and adult age 112 
groups were all gilts (female pigs that have not been used for breeding), whilst the 113 
older adults were ex-breeding sows.  Ethical permission for the study was granted by 114 
the University of Nottingham Animal Welfare Ethical Review Body (AWERB).  Pigs 115 
were group-housed under directives set by the Department of Environment, Food, 116 
and Rural Affairs (DEFRA), as specified in The Welfare of Farmed Animals 117 
(England) Regulations 2007, thus replicating the standards animals were housed in 118 
prior to arrival at our facilities. Animals were checked daily by qualified animal 119 
technicians.  Pigs were provided with free access to food and water and allowed to 120 
acclimatise to their surroundings upon arrival at the University facilities for a 121 
minimum of 2 weeks before being slaughtered by electrical stunning followed by 122 
exsanguination. The 63 wk animals were maintained for an extended period of time 123 
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(16-17 weeks), prior to euthanasia, to allow temporal changes in animal behaviour to 124 
be assessed. In all animals, after death had been confirmed, the stifles were 125 
removed for examination and tissue collection. 126 
 127 
Assessment of pain-associated behaviour 128 
Different aspects of pig behaviour including lameness, response to touch, willingness 129 
to ambulate and vocalisation were assessed as potential markers of behavioural 130 
pain in juvenile, adult and older adult pigs. Each behavioural aspect was 131 
incorporated into a scoring system and assigned a value from 1-5 (Supplementary 132 
Table 1) based on that used by Royal et al [17]. Behavioural assessment was carried 133 
out weekly and assessment sessions typically lasted about an hour. On arrival at the 134 
facility, pigs were allowed to acclimatise to the presence of the scorer for between 5-135 
10 minutes before behavioural scoring was carried out. Observation of lameness 136 
was carried out during weekly weighing procedures, with animals encouraged to 137 
move by the animal technicians. Similarly, the response to handling by the animal 138 
technician during the weighing process was used to record the response to touch. All 139 
other scoring parameters were collected on the same visit and prior to attempts to 140 
weight the animals, with animals resting in their home environment. 141 
 142 
Chondropathy scoring 143 
Femoral condyles and tibial plateaus of juvenile, adult, and older adult porcine 144 
femorotibial joints were used for chondropathy scoring. The lateral and medial 145 
surfaces of the femoral condyles and tibial plateaus of the joint were scored 146 
separately. Chondropathy scoring was performed using two methodologies, namely 147 
Collin’s grading and the revised Système Française D'Arthroscopie  (SFA) scoring 148 
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method as described by Walsh and colleagues [18].  The Collin’s grading and SFA 149 
are macroscopic severity scoring systems, which are based on an assessment of OA 150 
changes in the articular surface, including cartilage swelling, fibrillation and exposure 151 
of bone.  They have been widely validated in both mild and severe OA [18-23].  As a 152 
comparison to human OA, the femoral condyles and tibial plateau were also scored 153 
from end-stage knee OA patients (n=4), which were collected from the Royal 154 
Orthopaedic Hospital (Birmingham) following ethical approval from the Research 155 
Ethics Committee (NRES 13/NE/0222). In subsequent experiments, based on gross 156 
assessment, “damaged cartilage” was defined as having evidence of fibrillation, 157 
equivalent to a Collin’s grade score of greater than 2, or a revised SFA score of more 158 
than 20. Cartilage defined as “undamaged” had a normal, unbroken surface. 159 
 160 
Safranin-O staining of femoral condyle proteoglycans 161 
Femoral condyles from n=8 adult animals were snap frozen in liquid nitrogen 162 
immediately following slaughter and stored at -80°C until cryostat processing.  163 
Cryosections (8µm thick) were cut using a cryostat and transferred to slides to 164 
facilitate subsequent safranin-O/ fast green staining.  Staining was performed without 165 
fixation as described previously [24]. 166 
 167 
Culture of primary porcine chondrocytes, osteoblasts and cartilage explant 168 
Primary porcine chondrocytes were isolated from juvenile (n=6 animals) and older 169 
adult (n=6 animals) femoral condyle cartilage by collagenase digestion.  In brief, 170 
samples of cartilage were diced with a scalpel and digested for 4 h in chondrocyte 171 
cell culture media (DMEM supplemented with 10% FBS, 2mM L-glutamine, 1% non-172 
essential amino acids, 1% penicillin/streptomycin) containing 2mg/ml sterile-filtered 173 
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collagenase (Sigma Aldrich, Poole, UK).  The digested cartilage was filtered through 174 
a sterile 40 µm cell strainer, placed in T75 culture flasks with cell culture media and 175 
incubated at 37°C, 5% CO2.  Media was refreshed every 3-4 days. 176 
Osteoblasts were cultured out from subchondral bone chips obtained from adult 177 
(n=6) and older adult (n=6) pigs, based on a protocol we have previously used for 178 
human OA subchondral bone osteoblast outgrowth [25].  In brief, subchondral bone 179 
chips from damaged and non-damaged porcine femoral condyles were incubated in 180 
T75 culture flasks at 37°C, 5% CO2 in osteoblast cell culture media (DMEM 181 
supplemented with 10% FBS, 2mM L-glutamine, 1% non-essential amino acids, 1% 182 
penicillin/streptomycin, 2mM β-glycerophosphate, 50µg/ml L-ascorbic acid, 10nM 183 
dexamethasone and 1% amphotericin-B). After 7-20 days of culture, osteoblast 184 
outgrowth was observed and the bone chips were removed.  185 
Cartilage explants were prepared using a cork borer to cut cartilage discs (50 mm 186 
diameter) from full thickness sections of damaged and non-damaged femoral 187 
condyle cartilage obtained from adult animals (n=7) for sGAG analysis.  Cartilage 188 
explants were also prepared from older adult animals (n=5) for analysis of collagen 189 
mRNA and for in vitro cytokine stimulation.  Explant discs were placed into 96-well 190 
cell culture plates in chondrocyte cell culture media and incubated at 37°C, 5% CO2.  191 
 192 
1,9-dimethylmethylene blue (DMMB) proteoglycan release assay 193 
Sulphated glycosaminoglycan (sGAG) released from cartilage explant (n=7 adult 194 
animals) was quantified via a dimethylmethylene blue (DMMB) assay, as previously 195 
described [26].  In brief, cartilage explants were allowed to rest in chondrocyte media 196 
for 2-3 days before being replaced with fresh chondrocyte media and incubated for 197 
48 h, after which time the supernatant was collected for analysis.  Shark chondroiten 198 
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sulphate C (Sigma, UK) was used to generate a standard curve and 40 µL of 199 
standards and samples combined with 250 µL DMMB reagent  (0.24% sodium 200 
chloride, 0.3% glycine, 0.8% v/v hydrochloric acid, 0.0016% DMMB) and absorbance 201 
read at 550 nm using a microplate reader (Bio-Rad 680XR). 202 
 203 
Quantification of mRNA expression by qRT-PCR 204 
Total RNA was extracted from primary porcine chondrocytes using an RNA isolation 205 
kit (Roche High Pure Isolation Kit) according to the manufacturer’s instructions. Total 206 
RNA was extracted from snap-frozen porcine femoral condyle cartilage tissue using 207 
ceramic beads (Roche Green Beads) and a MagnaLyser instrument in combination 208 
with a fibrous tissue RNA extraction kit (Qiagen). cDNA was subsequently generated 209 
from 100 ng of total RNA (ReverAid RT cDNA synthesis kit, Thermo Scientific) 210 
according to manufacturer’s instructions. Relative mRNA expression of the collagen 211 
genes COL1A1 and COL2A1 were determined by qRTPCR using a Roche 212 
Lightcycler 480® (Roche, Burgess Hill, UK), normalised to cDNA concentration. The 213 
primer sequences used were as follows: COL1A1 Forward: 214 
AGAAGAAGACATCCCACCAGTCA, Reverse: CGTCATCGCACAACACATTG; 215 
COL2A1 Forward: GGCAACAGCAGGTTCACGTA, Reverse: 216 
CAATCATAGTCTGGCCCCACTT. All samples were analysed in triplicate. 217 
 218 
Alkaline Phosphatase (ALP) Assay 219 
Cultured osteoblasts were lysed using cell lysis buffer (150mM Sodium Chloride, 1% 220 
triton x-100, 50mM Tris, pH 8.0) containing protease and phosphatase inhibitor 221 
cocktails (Sigma Aldrich, Poole, UK) and the protein concentration of cell extract 222 
determined using the Bradford protein assay [27]. To 10µl osteoblast lysate, 100µl of 223 
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alkaline phosphatase substrate containing p-nitrophenylphosphate (pNNP) was 224 
added and incubated for 15 mins at 37°C before being stopped by the addition of 225 
20µl 0.1M sodium hydroxide. Standards prepared from human alkaline phosphatase 226 
diluted in 1mM magnesium chloride solution were run in parallel. Absorbance was 227 
measured at 405nm using a BioRad 680XR platereader. 228 
 229 
Alizarin Red Mineralisation Assay 230 
Mineralisation of osteoblasts was determined by Alizarin Red staining [28].  In brief, 231 
upon reaching confluence osteoblasts were grown for a further 3 weeks and then 232 
were stained with 0.5% alizarin red staining solution (0.5% Alizarin Red, 1% 233 
ammonia solution, pH 4.0) for 10 min.  The cells were then washed in PBS and 234 
destained using 10% cetyl pryridium chloride (Sigma, UK) for 10 min.  The 235 
absorbance of the supernatant was measured at 550 nm on a BioRad 680XR 236 
platereader. 237 
 238 
Mitochondrial assays 239 
To isolate mitochondria, osteoblasts were resuspended in 2ml Buffer (100mM 240 
potassium chloride, 50mM Tris, 5mM Magnesium Chloride, 1.8mM ATP, 1mM 241 
EDTA. pH 7.2) and homogenised on ice for 4 min.  The sample was then centrifuged 242 
at 720 x g for 1 min to pellet any cellular debris. The resultant supernatant was 243 
transferred to clean pre-cooled tube and centrifuged at 10000 x g for 5 min to pellet 244 
the mitochondria. The mitochondrial pellet was then resuspended in 400μl buffer 245 
(225mM sucrose, 44mM potassium phosphate monobasic, 12.5mM magnesium 246 
acetate, 6mM EDTA).   Maximal mitochondrial ATP production was measured using 247 
a 96-well bioluminescence assay.  In brief, 25μl of the mitochondrial sample was 248 
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added to 110μl Tris-EDTA buffer, 25μl ADP and 40μl ATP reagent SL (Biothema 249 
ATP Reagent SL Kit). All samples were run in triplicate and luminescence measured 250 
using a FLUOstar plate reader. Mitochondrial citrate synthase activity was measured 251 
based on the kinetic production of 2-nitro-5-benzoic acid measured at an absorbance 252 
of 415nm using a Bio-rad 680XR microplate reader. 253 
  254 
Statistical Analysis 255 
Statistical analysis was carried out using Graphpad Prism software version 7.0.  256 
Chondropathy scores and lameness scores were analysed using the Kruskall-Wallis 257 
non-parametric test, with post-hoc tests where appropriate. Pearson’s correlation 258 
coefficient was used to determine the relationship between proteoglycan loss and 259 
revised SFA chondropathy score. In vitro and ex-vivo expression data was analysed 260 
using unpaired t-tests with 1-way ANOVA used for dose responses.   261 
 262 
Results 263 
Development of lameness as a marker of pain-associated behaviour in the 264 
commercial pig  265 
Lameness was assessed in pigs at three different age groups, (i) juvenile (n=6), (ii) 266 
adult 63 week old pigs (n=6) and (iii) older adults (n=7). The adult pigs (63 week old) 267 
were monitored at weekly intervals over a 16 week period and lameness assessed 268 
from age 64 to 80 weeks, to allow temporal changes in pain-associated behaviour to 269 
be observed. Observational scoring of lameness indicators revealed no indications of 270 
lameness in the youngest age group (juvenile). However, there was a significant 271 
increase (p<0.05) in the median lameness of both 80 week adult and older adult 272 
pigs, compared to juvenile pigs (Figure 1A).  Furthermore, there was a significant 273 
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(p<0.01) increase in lameness score over a timespan of 16 weeks in adult pigs from 274 
age 64 to 80 weeks old (Figure 1B).  Lameness in the older adult animals was on 275 
average no greater than that observed in adult animals aged 80 wks (Figure 1A).  276 
None of the animals responded to touch in a manner that would be associated with 277 
pain or discomfort, or differed in their willingness to ambulate.  Furthermore, 278 
vocalisation was not related to any pain or discomfort as might be expected of other 279 
animals, such as the rat [29] for which VAS scoring is more commonly used. 280 
 281 
The commercial pig spontaneously develops signs of osteoarthritic joint 282 
damage 283 
Femorotibial joints from juvenile, adult, and older adult commercial pigs were 284 
assessed for the presence and severity of OA lesions by chondropathy scoring using 285 
Collin’s grading and a revised SFA scoring system.  As a comparison to human OA, 286 
femoral condyles and tibial plateau from end-stage human knee OA patients (n=4) 287 
were scored using the same chondropathy scoring system.    288 
Chondropathy scoring showed an effect of age and joint compartment on the 289 
development of joint damage in the commercial pig.  Using either Collin’s grading or 290 
revised SFA showed a significant increase in the median joint damage score in adult 291 
and older adult pigs, compared to juvenile pigs (Figure 2A, 2B).  As expected, the 292 
greatest joint damage was observed in the older adult pigs, which exhibited grade II 293 
and grade III lesions in femoral condyle cartilage (Figure 2C).  OA cartilage lesions 294 
developed on both tibial plateaus and femoral condyles, and on both medial and 295 
lateral sides of the joint.  However, in the older adult pigs significantly greater median 296 
joint damage was present on the medial side of the femoral condyles and on the 297 
medial side of tibial plateau, compared to the corresponding lateral compartments 298 
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(p<0.05) as scored using revised SFA (Figure 2A).  In addition to cartilage lesions, 299 
the joints of all older adult pigs animals, and the majority (75%) of 80 week adult pigs 300 
exhibited bony nodules, indicative of osteophyte formation (Figure 2D).  However, 301 
notably, joint damage, even in the older adult pigs was lower than that observed in 302 
end-stage human knee OA (Collin’s grade= 10.0 ± 1.1; SFA=106.4 ± 10.8). 303 
In order to further examine the pathology of these lesions we prepared cryosections 304 
of femoral condyle cartilage from n=8 adult pigs which exhibited varying degrees of 305 
joint damage, and stained the cartilage proteoglycans with Safranin O.  As expected, 306 
proteoglycan staining was appreciably lower in the cartilage sections prepared from 307 
pig joints that exhibited higher chondropathy scores (Figure 3A). We then assessed 308 
the relationship between proteoglycan degradation and joint damage by preparing 309 
cartilage explants from n=7 adult pigs with varying degrees of joint damage (femoral 310 
condyle SFA= 1.4, 2.1, 3.2, 7.6, 11.2, 13.4 and 30.5) and measuring the release of 311 
sGAGs, compared to non-damaged cartilage explant.  Due to the requirement to 312 
obtain full thickness cartilage explants of the same size (50 mm diameter) we did not 313 
determine sGAG release from explants of joints with higher chondropathy scores.  314 
Therefore, a limitation is that we have not assessed the relationship between 315 
cartilage explant sGAG release across the full range of joint damage scores in these 316 
animals.  Nevertheless, the relative release of sGAGs was positively correlated with 317 
both Collin’s grade (r2=0.791, p<0.01) and revised SFA score (r2 = 0.733, p<0.05) 318 
(Figure 3B).     319 
  320 
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Cytokine stimulation of primary porcine chondrocytes and cartilage explant 321 
induces IL-6 release and proteoglycan degradation 322 
Since human OA cartilage degeneration has been attributed to the hypertrophy and 323 
increased proliferative activity of chondrocytes, we first examined whether 324 
chondrocytes from the damaged joints of older adult pigs exhibited a greater 325 
proliferative capacity.  Comparing primary porcine chondrocytes isolated from older 326 
adult pigs with those isolated from juvenile animals, there was no difference in 327 
proliferation rate (Figure 4A).  However, similar to primary human chondrocytes, 328 
upon 2D culture porcine primary cells rapidly adopted a fibroblast-like morphology 329 
(Figure 4B) and exhibited a significantly lower ratio of COL2A1 to COL1A1 330 
expression compared to cartilage (Figure 4C; p<0.05), suggesting that the porcine 331 
chondrocyte phenotype is not maintained in culture.   332 
Next in porcine femoral condyle cartilage explants and isolated porcine chondrocytes 333 
obtained from older adult animals, we examined their utility as ex-vivo and in vitro 334 
OA models by determining the effect of putative pro-inflammatory drivers of OA 335 
cartilage degeneration on the release of the pro-inflammatory cytokine IL-6 (by 336 
ELISA) and sGAG release (by DMMB assay).  Stimulation for 24 h of primary 337 
porcine chondrocytes with either recombinant porcine IL-1β (0.1 ng/ml to 3 ng/ml) or 338 
recombinant visfatin (500 ng/ml) significantly increased IL-6 secretion, compared to 339 
unstimulated control (Figure 4D). Similarly, 24 h stimulation of porcine cartilage 340 
explants with either recombinant IL-1β (0.1 ng/ml to 1 ng/ml) or visfatin (500 ng/ml) 341 
significantly induced IL-6 secretion (Figure 4E), compared to unstimulated control 342 
cells. In addition, 24 h stimulation of porcine cartilage explant with IL-1β significantly 343 
induced the release of sGAGs (Figure 4F). 344 
 345 
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Porcine subchondral osteoblasts from OA damaged joints exhibit reduced 346 
proliferative and metabolic capacities and reduced ability to mineralise  347 
The presence of bony nodules in adult animals indicated the involvement of bone in 348 
the development of joint problems in the pig.  In human OA, the presence of 349 
osteophytes and changes to the subchondral bone trabecular structure has been 350 
attributed to an altered osteoblast phenotype [30] .  Therefore, we next compared the 351 
phenotype of osteoblasts isolated from both damaged and non-damaged joints from 352 
both adult and older adult pigs.   353 
The proliferative rate of osteoblasts obtained from non-damaged adult joints was 354 
significantly (p<0.01) greater than in osteoblasts from the older adult damaged joints 355 
(Figure 5A).  In addition, the osteoblasts from non-damaged adult joints, but not 356 
osteoblasts from the damaged older adult joints, were able to form mineralised bone 357 
nodules over 21 d culture as noted by positive staining of mineral with Alizarin red 358 
(Figure 5B).  Furthermore, while not statistically significant, a trend for osteoblasts 359 
from damaged older adult joints to exhibit greater ALP activity than osteoblasts from 360 
adult non-damaged joints was observed (P=0.09; Figure 5C).  361 
To investigate this further, we next examined mitochondrial activity by determining 362 
both mitochondrial ATP production and citrate synthase activity in osteoblasts from 363 
damaged and non-damaged joints collected either adult or older adult pigs.  There 364 
was a highly significant (p<0.01) effect of joint damage on both mitochondrial ATP 365 
production (Figure 5D) and citrate synthase activity (Figure 5E), with osteoblasts 366 
from damaged joints exhibiting reduced mitochondrial ATP production and citrate 367 
synthase activity, compared to osteoblasts from non-damaged joints, in both adult 368 
and older adult pigs.   369 
 370 
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Discussion 371 
This study is the first to report the temporal and spontaneous development of OA in 372 
the femorotibial joint of the commercial pig and its association with behavioural pain.  373 
Furthermore, for the first time we provide evidence of impaired proliferative, 374 
metabolic and mineralisation capacity of subchondral osteoblasts from OA damaged 375 
joints in the pig.    376 
Examination of porcine femorotibial joints by two different chondropathy scoring 377 
systems (revised SFA and Collin’s grade) revealed that commercial pigs develop 378 
osteoarthritic lesions in their femorotibial joints early in their lifespan.  Importantly, 379 
significantly greater total cartilage damage was observed on the medial side of the 380 
joint compared to the lateral compartments in the older adult pigs, as often observed 381 
in the development of human OA knee which has been attributed to gait [10].  382 
Similarly to human OA, articular cartilage from damaged pig joints exhibited lower 383 
proteoglycan content than that collected from non-damaged joints.  In human OA, 384 
cartilage proteoglycan matrix degradation is attributed to the proliferation and 385 
hypertrophy of chondrocytes.  In this study, we observed no difference in the 386 
proliferative capacity of porcine primary chondrocytes isolated from juvenile joints 387 
compared to chondrocytes isolated from damaged older adult pig joints.  However, 388 
similarly to human OA chondrocytes [31-33] porcine chondrocytes rapidly de-389 
differentiated in culture, exhibiting a fibroblast-like morphology and expressed 390 
significantly lower type II collagen compared to porcine cartilage.        391 
In addition to cartilage damage, the joints of adult pigs exhibited bony nodules 392 
indicative of osteophyte formation and aberrant subchondral bone remodelling [34].  393 
Evidence of abnormalities in the subchondral bone early in the development of joint 394 
damage in the pig adds further weight to the role of bone in the initiation and 395 
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progression of OA [2, 35, 36].  In human OA, the appearance of bony spurs can be 396 
seen on radiographs of the diseased joint, whilst MRI analysis has shown that the 397 
presence of bone marrow lesions in subchondral bone are associated with the 398 
progression of cartilage loss [37, 38] and pain [39, 40].  Further analysis by MicroCT 399 
has shown that the subchondral bone in OA is under-mineralised but has thicker 400 
trabeculae [41], suggestive of accelerated bone turnover. In addition to our findings 401 
in the pig, changes to the subchondral bone have been reported during the  402 
spontaneous development of OA in the Dunkin Harltey guinea pig [42], where bone 403 
changes were found to occur prior to significant cartilage loss [43]. 404 
In this study, further evidence for the involvement of bone in the spontaneous 405 
development of OA in the pig was observed upon analysis of isolated porcine 406 
osteoblasts from the subchondral bone tissue of damaged joints and non-damaged 407 
joints.  Both proliferative and mineralisation capacity was found to be impaired in 408 
osteoblasts from damaged joints of older adult animals compared to osteoblasts 409 
from younger non-damaged joints. Conversely, osteoblasts from damaged joints of 410 
older adult animals exhibited greater ALP activity compared to osteoblasts from 411 
younger non-damaged joints. It is important to note however, that we did not 412 
compare the proliferative activity of osteoblasts from damaged and non-damaged 413 
joints within the same age group.  We cannot therefore be certain whether this 414 
impaired proliferative osteoblast phenotype is due to age or disease.  However, this 415 
“damaged” porcine osteoblast phenotype has similarities to the human OA 416 
osteoblast phenotype. For example, human OA subchondral osteoblasts have 417 
elevated ALP activity, compared to non-OA osteoblasts [44]. Furthermore, Sanchez 418 
et al [45] have found that osteoblasts from regions of sclerotic subchondral bone 419 
tissue exhibit greater ALP activity and reduced mineralization, compared to non-420 
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sclerotic osteoblasts from OA joints.  This high ALP activity but lower mineralisation 421 
capacity in OA osteoblasts has been attributed to the potential accumulation of 422 
pyrophosphate (PPi) activating ALP, whilst being a potent inhibitor of 423 
hydroxyapaptite crystal formation [45].   424 
It has previously been proposed that the phenotype of elevated ALP coupled with 425 
reduced mineralisation in OA osteoblasts indicates that subchondral bone 426 
osteoblasts undergo incomplete differentiation in human OA [46]. Since 427 
mitochondrial activity plays a critical role in osteoblast differentiation [47, 48] it is 428 
notable that we found that osteoblasts from damaged pig joints exhibited significantly 429 
lower mitochondrial ATP production than osteoblasts from non-damaged joints.  430 
Mitochondrial activity has been implicated as a mediator of OA pathology [49, 50].  431 
Indeed, reduced mitochondrial activity in OA chondrocytes has been implicated in 432 
cartilage damage [51]. Currently, despite mitochondrial activity being central to 433 
osteoblast differentiation, studies investigating mitochondria in OA osteoblasts are 434 
lacking.  However, osteoblast mitochondrial dysfunction has been identified as an 435 
important factor in the pathogenesis of osteoporosis [52]. Our finding that citrate 436 
synthase activity was also reduced in osteoblasts from damaged pig joints suggests 437 
joint damage in the pig was associated with a reduction in subchondral osteoblast 438 
mitochondrial number, rather than osteoblast mitochondrial dysfunction.    439 
In addition to the spontaneous development of OA joint damage, the commercial pig 440 
represents an excellent tissue source for in vitro and ex-vivo OA models.  Indeed, 441 
cultured osteoblasts retained a “damaged” dysfunctional phenotype in vitro.  442 
Furthermore, although isolated chondrocytes rapidly de-differentiated upon 2D 443 
culture, both chondrocytes and cartilage explants were highly responsive to 444 
stimulation with pro-inflammatory putative OA drivers including IL-1β and visfatin, 445 
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with a rapid quantitative secretion of IL-6, and sGAG release.  Critically, such studies 446 
on human cartilage most often utilise tissue from end-stage OA patients where the 447 
cartilage is highly degraded. Therefore, the availability of sufficient quantity of 448 
relatively healthy cartilage tissue that behaves in a similar manner may represent a 449 
useful tissue source for conducting studies that better represent early OA initiation.    450 
The use of the commercial pig as a spontaneous model of OA has some limitations.  451 
Pigs can develop osteochondrosis (OC), which commonly occurs in fast growing 452 
animals and can lead to the development of OA which is secondary [53]. Also, while 453 
the Large white x Landrace x Duroc, as used in the current study, is commonly 454 
utilized for commercial purposes, it is feasible that differences in the development of 455 
OA could be seen between different genotypes of pig.  A limitation of the current 456 
study is the narrow range of recombinant proteins considered in our ex vivo assays. 457 
The response of cartilage explants from the pig femorotibial joint to alternative 458 
proteins implicated in the etiology of human osteoarthritis remains to be confirmed. 459 
Furthermore, the cytokine stimulations of porcine chondrocytes and cartilage explant 460 
were conducted in full serum culture media.  This was done in order to mimic 461 
previous studies in on cytokine stimulation of human cartilage and human 462 
chondrocytes [54, 55].  However, it should be noted that Bian et al. showed that 463 
cartilage explant cultured in full-serum exhibited 70% greater degradation over the 464 
course of 2 weeks compared to cartilage in serum-free media [56].  Finally, it 465 
remains to be determined whether histological examination of the subchondral bone 466 
of the pig femorotibial joint will reveal similar pathophysiological changes as evident 467 
in humans. 468 
 469 
Conclusion 470 
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The commercial pig spontaneously develops behavioural pain and OA joint damage 471 
in the femorotibial joint with evidence of cartilage lesions in the femoral condyles and 472 
tibial plateau and metabolically dysfunctional subchondral bone osteoblasts.  The 473 
commercial pig may therefore provide an alternative preclinical model of OA and a 474 
highly useful source of joint tissue for in vitro and ex vivo OA models.   475 
 476 
Abbreviations 477 
OA: osteoarthritis; DMOADs: disease modifying OA drugs; SFA: Système Française 478 
D'Arthroscopie; AWERB: Animal Welfare Ethical Review Body; DMMB: 1,9-479 
dimethylmethylene blue; sGAG: Sulphated glycosaminoglycan; ALP: Alkaline 480 
Phosphatase; pNNP: p-nitrophenylphosphate. FCL: Femoral condoyle – lateral 481 
surface; FCM: Femoral condoyle – medial surface; TPL: Tibial plateau – lateral 482 
surface; TPM: Tibial plateau – medial surface. 483 
 484 
Declarations 485 
Ethics approval and consent to participate 486 
This study was approved by the University of Nottingham Animal Welfare Ethical 487 
Review Body (AWERB).  The collection and use of human OA joint tissue was 488 
approved by the National Research Ethics Committee (NRES 13/NE/0222) and 489 
written informed consent was obtained from patients. 490 
 491 
Consent to publish 492 
Not applicable 493 
 494 
Availability of data and materials 495 
20  
The datasets supporting the conclusions of this article are included within the article. 496 
If you wish to obtain access for the underlying material please contact the 497 
corresponding author to discuss your request in detail. 498 
 499 
Competing interests 500 
Dr Simon Jones is a member of the Editorial Board of BMC Musculoskeletal 501 
Disorders. The authors declare that they have no other competing interests 502 
 503 
Funding 504 
Mhairi Macfadyen was supported by a MRC-ARUK Centre for Musculoskeletal 505 
Ageing Research PhD studentship (MR/K00414X/1). The funding agency had no 506 
input in to the design of the study, the collection, analysis and interpretation of data, 507 
the writing of the manuscript, or the decision to publish. 508 
 509 
Authors’ contributions 510 
MM performed data collection, analysis of data and drafted the manuscript. ZD 511 
performed data collection, analysis of data.  SK performed data collection and 512 
analysis of data.  TP, JMB, AJM and SWJ conceived and designed the study, 513 
analysed the data and wrote the manuscript.  All authors approved the final 514 
manuscript. 515 
 516 
Acknowledgments 517 
The authors would like to thank Kirsty Jewell (University of Nottingham) for technical 518 
support. 519 
  520 
21  
REFERENCES 521 1. Murray CJ, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, Bennett D, 522 Bernabe E, Blencowe H, Bourne R et al: UK health performance: findings of the Global 523 Burden of Disease Study 2010. Lancet 2013, 381(9871):997-1020. 524 2. Tonge DP, Pearson MJ, Jones SW: The hallmarks of osteoarthritis and the potential to 525 develop personalised disease-modifying pharmacological therapeutics. Osteoarthritis 526 
Cartilage 2014, 22(5):609-621. 527 3. Philp AM, Davis ET, Jones SW: Developing anti-inflammatory therapeutics for patients 528 with osteoarthritis. Rheumatology (Oxford) 2017, 56(6):869-881. 529 4. Chen A, Gupte C, Akhtar K, Smith P, Cobb J: The Global Economic Cost of Osteoarthritis: 530 How the UK Compares. Arthritis 2012, 2012:698709. 531 5. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, 532 Guillemin F, Hill CL et al: The global burden of hip and knee osteoarthritis: estimates 533 from the global burden of disease 2010 study. Ann Rheum Dis 2014, 73(7):1323-1330. 534 6. Thysen S, Luyten FP, Lories RJ: Targets, models and challenges in osteoarthritis 535 research. Dis Model Mech 2015, 8(1):17-30. 536 7. Brandt KD, Braunstein EM, Visco DM, O'Connor B, Heck D, Albrecht M: Anterior (cranial) 537 cruciate ligament transection in the dog: a bona fide model of osteoarthritis, not merely 538 of cartilage injury and repair. J Rheumatol 1991, 18(3):436-446. 539 8. Culley KL, Dragomir CL, Chang J, Wondimu EB, Coico J, Plumb DA, Otero M, Goldring MB: 540 Mouse models of osteoarthritis: surgical model of posttraumatic osteoarthritis induced 541 by destabilization of the medial meniscus. Methods Mol Biol 2015, 1226:143-173. 542 9. Glasson SS, Blanchet TJ, Morris EA: The surgical destabilization of the medial meniscus 543 (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 2007, 544 15(9):1061-1069. 545 10. Bendele AM: Animal models of osteoarthritis. J Musculoskelet Neuronal Interact 2001, 546 1(4):363-376. 547 11. Mak IWY, Evaniew N, Ghert M: Lost in translation: animal models and clinical trials in 548 cancer treatment. Am J Transl Res 2014, 6(2):114-118. 549 12. Jimenez PA, Glasson SS, Trubetskoy OV, Haimes HB: Spontaneous osteoarthritis in 550 Dunkin Hartley guinea pigs: histologic, radiologic, and biochemical changes. Lab Anim 551 
Sci 1997, 47(6):598-601. 552 13. Tonge DP, Bardsley RG, Parr T, Maciewicz RA, Jones SW: Evidence of changes to skeletal 553 muscle contractile properties during the initiation of disease in the ageing guinea pig 554 model of osteoarthritis. Longev Healthspan 2013, 2(1):15. 555 14. McIlwraith CW, Frisbie DD, Kawcak CE: The horse as a model of naturally occurring 556 osteoarthritis. Bone Joint Res 2012, 1(11):297-309. 557 15. Liu W, Burton-Wurster N, Glant TT, Tashman S, Sumner DR, Kamath RV, Lust G, Kimura 558 JH, Cs-Szabo G: Spontaneous and experimental osteoarthritis in dog: similarities and 559 differences in proteoglycan levels. J Orthop Res 2003, 21(4):730-737. 560 16. Jorgensen B, Sorensen MT: Different rearing intensities of gilts: II. Effects on subsequent 561 leg weakness and longevity. Livest Prod Sci 1998, 54(2):167-171. 562 17. Royal JM, Settle TL, Bodo M, Lombardini E, Kent ML, Upp J, Rothwell SW: Assessment of 563 postoperative analgesia after application of ultrasound-guided regional anesthesia for 564 surgery in a swine femoral fracture model. J Am Assoc Lab Anim Sci 2013, 52(3):265-565 276. 566 18. Walsh DA, Yousef A, McWilliams DF, Hill R, Hargin E, Wilson D: Evaluation of a 567 Photographic Chondropathy Score (PCS) for pathological samples in a study of 568 inflammation in tibiofemoral osteoarthritis. Osteoarthritis Cartilage 2009, 17(3):304-569 312. 570 19. Hopwood B, Tsykin A, Findlay DM, Fazzalari NL: Microarray gene expression profiling of 571 osteoarthritic bone suggests altered bone remodelling, WNT and transforming growth 572 factor-beta/bone morphogenic protein signalling. Arthritis Res Ther 2007, 9(5):R100. 573 
22  
20. Kuettner KE, Cole AA: Cartilage degeneration in different human joints. Osteoarthritis 574 
Cartilage 2005, 13(2):93-103. 575 21. Ayral X, Gueguen A, Listrat V, Bahuaud J, Beaufils P, Beguin J, Bonvarlet JP, Boyer T, 576 Coudane H, Delaunay C et al: [Proposal of a simplified arthroscopic score of cartilage 577 lesions of the knee (simplified SFA score)]. Rev Rhum Ed Fr 1994, 61(2):97-99. 578 22. Dougados M, Ayral X, Listrat V, Gueguen A, Bahuaud J, Beaufils P, Beguin JA, Bonvarlet JP, 579 Boyer T, Coudane H et al: The SFA system for assessing articular cartilage lesions at 580 arthroscopy of the knee. Arthroscopy 1994, 10(1):69-77. 581 23. Ravaud P, Giraudeau B, Auleley GR, Chastang C, Poiraudeau S, Ayral X, Dougados M: 582 Radiographic assessment of knee osteoarthritis: reproducibility and sensitivity to 583 change. J Rheumatol 1996, 23(10):1756-1764. 584 24. Schmitz N, Laverty S, Kraus VB, Aigner T: Basic methods in histopathology of joint 585 tissues. Osteoarthritis Cartilage 2010, 18 Suppl 3:S113-116. 586 25. Chang J, Jackson SG, Wardale J, Jones SW: Hypoxia modulates the phenotype of 587 osteoblasts isolated from knee osteoarthritis patients, leading to undermineralized bone 588 nodule formation. Arthritis Rheumatol 2014, 66(7):1789-1799. 589 26. Burkhardt D, Hwa SY, Ghosh P: A novel microassay for the quantitation of the sulfated 590 glycosaminoglycan content of histological sections: its application to determine the 591 effects of Diacerhein on cartilage in an ovine model of osteoarthritis. Osteoarthritis 592 
Cartilage 2001, 9(3):238-247. 593 27. Bradford MM: A rapid and sensitive method for the quantitation of microgram 594 quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 595 72:248-254. 596 28. Gregory CA, Gunn WG, Peister A, Prockop DJ: An Alizarin red-based assay of 597 mineralization by adherent cells in culture: comparison with cetylpyridinium chloride 598 extraction. Anal Biochem 2004, 329(1):77-84. 599 29. Deuis JR, Dvorakova LS, Vetter I: Methods Used to Evaluate Pain Behaviors in Rodents. 600 
Front Mol Neurosci 2017, 10:284. 601 30. Maruotti N, Corrado A, Cantatore FP: Osteoblast role in osteoarthritis pathogenesis. J Cell 602 
Physiol 2017, 232(11):2957-2963. 603 31. Benya PD, Padilla SR, Nimni ME: Independent regulation of collagen types by 604 chondrocytes during the loss of differentiated function in culture. Cell 1978, 15(4):1313-605 1321. 606 32. Cooke M, Pearson MJ, Williams RL, Grover LM, Jones SW: Characterisation of the 607 Biochemical and Biophysical Properties of Biomimetic Cartilage Models. Osteoarthr 608 
Cartilage 2016, 24:S172-S173. 609 33. von der Mark K, Gauss V, von der Mark H, Muller P: Relationship between cell shape and 610 type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. 611 
Nature 1977, 267(5611):531-532. 612 34. Kuyinu EL, Narayanan G, Nair LS, Laurencin CT: Animal models of osteoarthritis: 613 classification, update, and measurement of outcomes. J Orthop Surg Res 2016, 11:19. 614 35. Radin EL: Subchondral bone changes and cartilage damage. Equine Vet J 1999, 31(2):94-615 95. 616 36. Radin EL, Abernethy PJ, Townsend PM, Rose RM: The role of bone changes in the 617 degeneration of articular cartilage in osteoarthrosis. Acta Orthop Belg 1978, 44(1):55-618 63. 619 37. Felson DT, McLaughlin S, Goggins J, LaValley MP, Gale ME, Totterman S, Li W, Hill C, Gale 620 D: Bone marrow edema and its relation to progression of knee osteoarthritis. Ann Intern 621 
Med 2003, 139(5 Pt 1):330-336. 622 38. Hunter DJ, Zhang Y, Niu J, Goggins J, Amin S, LaValley MP, Guermazi A, Genant H, Gale D, 623 Felson DT: Increase in bone marrow lesions associated with cartilage loss: a longitudinal 624 magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum 2006, 625 54(5):1529-1535. 626 
23  
39. Neogi T: Clinical significance of bone changes in osteoarthritis. Ther Adv Musculoskelet 627 
Dis 2012, 4(4):259-267. 628 40. Felson DT, Chaisson CE, Hill CL, Totterman SM, Gale ME, Skinner KM, Kazis L, Gale DR: 629 The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 630 2001, 134(7):541-549. 631 41. Hunter DJ, Gerstenfeld L, Bishop G, Davis AD, Mason ZD, Einhorn TA, Maciewicz RA, 632 Newham P, Foster M, Jackson S et al: Bone marrow lesions from osteoarthritis knees are 633 characterized by sclerotic bone that is less well mineralized. Arthritis Res Ther 2009, 634 11(1):R11. 635 42. Anderson-MacKenzie JM, Quasnichka HL, Starr RL, Lewis EJ, Billingham ME, Bailey AJ: 636 Fundamental subchondral bone changes in spontaneous knee osteoarthritis. Int J 637 
Biochem Cell Biol 2005, 37(1):224-236. 638 43. Quasnichka HL, Anderson-MacKenzie JM, Bailey AJ: Subchondral bone and ligament 639 changes precede cartilage degradation in guinea pig osteoarthritis. Biorheology 2006, 640 43(3,4):389-397. 641 44. Hilal G, Martel-Pelletier J, Pelletier JP, Ranger P, Lajeunesse D: Osteoblast-like cells from 642 human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: 643 possible role in subchondral bone sclerosis. Arthritis Rheum 1998, 41(5):891-899. 644 45. Sanchez C, Deberg MA, Bellahcene A, Castronovo V, Msika P, Delcour JP, Crielaard JM, 645 Henrotin YE: Phenotypic characterization of osteoblasts from the sclerotic zones of 646 osteoarthritic subchondral bone. Arthritis Rheum 2008, 58(2):442-455. 647 46. Couchourel D, Aubry I, Delalandre A, Lavigne M, Martel-Pelletier J, Pelletier JP, 648 Lajeunesse D: Altered mineralization of human osteoarthritic osteoblasts is attributable 649 to abnormal type I collagen production. Arthritis Rheum 2009, 60(5):1438-1450. 650 47. Gao J, Feng Z, Wang X, Zeng M, Liu J, Han S, Xu J, Chen L, Cao K, Long J et al: SIRT3/SOD2 651 maintains osteoblast differentiation and bone formation by regulating mitochondrial 652 stress. Cell Death Differ 2018, 25(2):229-240. 653 48. Tejerina S, De Pauw A, Vankoningsloo S, Houbion A, Renard P, De Longueville F, Raes M, 654 Arnould T: Mild mitochondrial uncoupling induces 3T3-L1 adipocyte de-differentiation 655 by a PPARgamma-independent mechanism, whereas TNFalpha-induced de-656 differentiation is PPARgamma dependent. J Cell Sci 2009, 122(Pt 1):145-155. 657 49. Blanco FJ, Rego I, Ruiz-Romero C: The role of mitochondria in osteoarthritis. Nat Rev 658 
Rheumatol 2011, 7(3):161-169. 659 50. Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R: Mitochondrial 660 oxidative phosphorylation is a downstream regulator of nitric oxide effects on 661 chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000, 43(7):1560-662 1570. 663 51. Maneiro E, Martin MA, de Andres MC, Lopez-Armada MJ, Fernandez-Sueiro JL, del Hoyo 664 P, Galdo F, Arenas J, Blanco FJ: Mitochondrial respiratory activity is altered in 665 osteoarthritic human articular chondrocytes. Arthritis Rheum 2003, 48(3):700-708. 666 52. Ding G, Zhao J, Jiang D: Allicin inhibits oxidative stress-induced mitochondrial 667 dysfunction and apoptosis by promoting PI3K/AKT and CREB/ERK signaling in 668 osteoblast cells. Exp Ther Med 2016, 11(6):2553-2560. 669 53. Pascual-Garrido C, McNickle AG, Cole BJ: Surgical treatment options for osteochondritis 670 dissecans of the knee. Sports Health 2009, 1(4):326-334. 671 54. Jones SW, Brockbank SM, Clements KM, Le Good N, Campbell D, Read SJ, Needham MR, 672 Newham P: Mitogen-activated protein kinase-activated protein kinase 2 (MK2) 673 modulates key biological pathways associated with OA disease pathology. Osteoarthritis 674 
Cartilage 2009, 17(1):124-131. 675 55. Jones SW, Brockbank SM, Mobbs ML, Le Good NJ, Soma-Haddrick S, Heuze AJ, Langham 676 CJ, Timms D, Newham P, Needham MR: The orphan G-protein coupled receptor RDC1: 677 evidence for a role in chondrocyte hypertrophy and articular cartilage matrix turnover. 678 
Osteoarthritis Cartilage 2006, 14(6):597-608. 679 
24  
56. Bian L, Lima EG, Angione SL, Ng KW, Williams DY, Xu D, Stoker AM, Cook JL, Ateshian GA, 680 Hung CT: Mechanical and biochemical characterization of cartilage explants in serum-681 free culture. J Biomech 2008, 41(6):1153-1159. 682 
 683 684 
25  
Figure legends: 685 
Figure 1.  Development of lameness as a marker of behavioural pain. 686 
A scoring system was used to assess lameness as a marker of behavioural pain.  687 
(A) Comparison of median lameness score in juvenile (n=6 animals), 80 wk adult 688 
(n=6 animals) and older adult (n=7 animals) pigs.  *=p<0.05, significantly different 689 
from juvenile lameness score as determined by Kruskal-Wallis non-parametric test 690 
with Dunn’s post-hoc test.  (B)  Median lameness score in adult pigs across an 16 691 
week timespan from age 64 to 80 wk old (n= 6 animals).   **=p<0.01, significant 692 
change in median score over time as determined by Kruskal-Wallis test.     693 
 694 
Figure 2.  Spontaneous development of joint damage in the commercial pig 695 
(A) Median total and joint compartment chondropathy score of femoral condyle and 696 
tibial plateau joints using Collin’s grading and Revised SFA in juvenile (white boxes, 697 
n=6), adult (light grey boxes, n=14)  and older adult (dark grey boxes, n=7) pigs. * = 698 
p<0.05; ** = p<0.01; *** = p<0.001 significantly different compared to juvenile 699 
animals.  ψ = p<0.05 significantly different between medial and lateral compartment 700 
within same age group, as determined using Kruskal-Wallis non-parametric test.  (B) 701 
Representative images of femoral condyle joints from juvenile, adult, and older adult 702 
animals.  (C) Evidence of Grade II and Grade III cartilage lesions in femoral condyles 703 
of older adult pigs. (D) Evidence of bony nodules in adult pigs.   FCM= femoral 704 
condyle medial, FCL=femoral condyle lateral, TPM=tibital plateau medial, TPL=tibial 705 
plateau lateral. 706 
 707 
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Figure 3.  Areas of cartilage damage exhibit proteoglycan loss. 708 
(A) Representative images (10X magnification) of Safranin O staining of 709 
proteoglycan in femoral medial condyle cryosections from n=8 adult pigs with varying 710 
signs of joint damage.  White numbers represent SFA of the femoral condyle joint 711 
(medial plus lateral).  Yellow numbers represent the SFA score of the whole joint 712 
(femoral condyle and tibial plateau).  (B) Correlation between chondropathy scoring 713 
(SFA and Collins) and sGAG release from femoral condyle cartilage explants 714 
prepared from n=7 adult pig joints.   sGAG release was measured by DMMB assay 715 
and is expressed as the relative fold difference in damaged cartilage compared to 716 
healthy undamaged control cartilage explant.  r = Pearson’s correlation coefficient.   717 
 718 
Figure 4.  Characterisation of porcine chondrocytes and cartilage explant 719 
(A) Proliferation of primary porcine chondrocytes isolated from juvenile (n=6) and 720 
older adult pigs (n=6).  Proliferation was determined by MTS assay over a 721 
timecourse of 14 days.  (B)  Representative light microscope image (6.3X 722 
magnification) of porcine chondrocytes in 2D culture showing fibroblast-like 723 
morphology. (C)  mRNA expression of type I and Type II collagen in primary porcine 724 
chondrocytes (n=6 animals) compared to non-damaged porcine cartilage explant 725 
(n=5 animals), from older adult pigs.  Expression was determined by qRT-PCR 726 
normalised to total cDNA concentration.  (D)  Secretion of IL-6 from porcine primary 727 
chondrocytes from older adult pigs (n=6) stimulated for 24 h with recombinant IL-1β 728 
(0.1-3 ng/ml) or recombinant visfatin (500 ng/ml).  IL-6 in cell supernatants was 729 
measured by ELISA.  * = p<0.05; *** = p<0.001 significantly different from un-730 
stimulated control chondrocytes.  Bars represent mean ± SEM (n=6).  (E)  Secretion 731 
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of IL-6 from porcine non-damaged cartilage explants from older adult pigs stimulated 732 
for 24 h with recombinant IL-1β (0.1-10 ng/ml) or recombinant visfatin (500 mg/ml) as 733 
measured by ELISA.  * = p<0.05; *** = p<0.001 significantly different from un-734 
stimulated control explants.  Bars represent mean ± SEM (n=20 explants per 735 
stimulant).  (F) Detection of sulphated glycosaminoglycan (sGAG) proteoglycan side-736 
chain upon 24 h stimulation of porcine non-damaged cartilage explant from older 737 
adult pigs with recombinant IL-1B.  sGAG detected by DMMB assay.   * = p<0.05; *** 738 
= p<0.001 significantly different from un-stimulated control explants.  Bars represent 739 
mean ± SEM (n=20 explants per stimulant)     740 
 741 
Figure 5: (A) Proliferation of osteoblasts obtained from non-damaged adult and 742 
damaged older adult pig joints measured over a 14 day time period by MTS assay. 743 
Data points represent the mean cell number ± SEM (n=3). (B) Representative light 744 
microscope images of alizarin red stained osteoblasts isolated from non-damaged 745 
adult and damaged older adult joints.  (C)  ALP activity isolated from non-damaged 746 
adult (n=3 animals) and damaged older adult joints (n=3 animals).  Values represent 747 
mean ALP activity ± SEM.  (D) Maximal mitochondrial ATP production in osteoblasts 748 
obtained from adult (n=3 non-damaged; n=3 damaged) and older adult (n=3 non-749 
damaged; n=3 damaged) pig joints.  ** = p<0.01.  Bars represent mean ±SEM.  (E) 750 
Citrate synthase activity in osteoblasts obtained from adult (n=3 non-damaged; n=3 751 
damaged) and older adult (n=3 non-damaged; n=3 damaged) pig joints.  Bars 752 
represent mean ± SEM. ** = p<0.01, *** = p<0.001.      753 
  754 
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